Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CRSP

CRISPR Therapeutics AG

Jun 11 • 04:00PM ET

50.23

+0.79 1.60 %

Healthcare • Biotechnology • Switzerland • Mid • NASD

Peers: BEAM NTLA EDIT BMRN INCY VIR ALNY IONS VRTX JAN

| Held by: ARKK IWM ARKG XBI VXF IWN IBB VTWO SCHA SCHM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.21	Insider Own	7.16%	Shs Outstand	96.39M	Perf Week	-11.80%
Market Cap	4.84B	Forward P/E	-	EPS next Y	-3.70	Insider Trans	-3.26%	Shs Float	89.54M	Perf Month	-4.92%
Enterprise Value	3.19B	PEG	-	EPS next Q	-1.20	Inst Own	72.72%	Short Float	24.20%	Perf Quarter	2.78%
Income	-568.53M	P/S	1181.62	EPS this Y	25.36%	Inst Trans	0.80%	Short Ratio	11.87	Perf Half Y	-11.94%
Sales	4.10M	P/B	2.67	EPS next Y	23.39%	ROA	-23.24%	Short Interest	21.67M	Perf YTD	-4.21%
Book/sh	18.83	P/C	1.98	EPS next 5Y	26.48%	ROE	-31.21%	52W High	78.48 -36.00%	Perf Year	20.98%
Cash/sh	25.32	P/FCF	-	EPS past 3/5Y	8.21% -4.10%	ROIC	-22.01%	52W Low	39.81 26.17%	Perf 3Y	-17.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	43.09% 37.31%	Gross Margin	-5283.40%	Volatility	6.11% 5.21%	Perf 5Y	-60.45%
Dividend TTM	-	EV/Sales	778.07	EPS Y/Y TTM	-37.55%	Oper. Margin	-13408.29%	ATR (14)	2.96	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.96	Sales Y/Y TTM	-89.11%	Profit Margin	-13856.54%	RSI (14)	45.63	Recom	1.85
Dividend Gr. 3/5Y	- -	Current Ratio	17.96	EPS Q/Q	19.13%	SMA20	-2.59%	Beta	1.71	Target Price	81.10
Payout	-	Debt/Eq	0.43	Sales Q/Q	68.55%	SMA50	-4.31%	Rel Volume	0.83	Prev Close	49.44
Employees	-	LT Debt/Eq	0.42	Earnings	May 04 AMC	SMA200	-9.58%	Avg Volume	1.83M	Price	50.23
IPO	Oct 19, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.05% -75.96%	Trades		Volume	1,511,559	Change	1.60%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)